Abstract
Preterm birth (delivery before 37 completed weeks of pregnancy) is a major problem worldwide, leading to high mortality and significant long-term morbidity. A complex interaction between ascending lower genital tract infection and the maternal immune system is a likely underlying component of pathogenesis. In this chapter we consider the ways in which expression of antimicrobial peptides in the maternal genital tract may modulate the risk of ascending genital tract infection and thus the risk of preterm birth.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abbott DS, Chin-Smith EC, Seed PT, Chandiramani M, Shennan AH, Tribe RM (2014) Raised trappin2/elafin protein in cervico-vaginal fluid is a potential predictor of cervical shortening and spontaneous preterm birth. PLoS ONE 9(7):e100771
Africander D, Louw R, Verhoog N, Noeth D, Hapgood JP (2011) Differential regulation of endogenous pro-inflammatory cytokine genes by medroxyproges-terone acetate and norethisterone acetate in cell lines of the female genital tract. Contraception 84(4):423–435
Bajaj-Elliott M, Fedeli P, Smith GV, Domizio P, Maher L, Ali RS, Quinn AG, Farthing MJ (2002) Modulation of host antimicrobial peptide (beta-defensins 1 and 2) expression during gastritis. Gut 51(3):356–361
Becher N, Adams Waldorf K, Hein M, Uldbjerg N (2009) The cervical mucus plug: structured review of the literature. Acta Obstet Gynecol Scand 88(5):502–513
Blencowe H, Cousens S, Oestergaard MZ, Chou D, Moller AB, Narwal R, Adler A, Vera Garcia C, Rohde S, Say L, Lawn JE (2012) National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet 379(9832):2162–2172
Buhimschi CS, Dulay AT, Abdel-Razeq S, Zhao G, Lee S, Hodgson EJ, Bhandari V, Buhimschi IA (2009) Fetal inflammatory response in women with proteomic biomarkers characteristic of intra-amniotic inflammation and preterm birth. BJOG 116(2):257–267
Cobo T, Palacio M, Martinez-Terron M, Navarro-Sastre A, Bosch J, Filella X, Gratacos E (2011) Clinical and inflammatory markers in amniotic fluid as predictors of adverse outcomes in preterm premature rupture of membranes. Am J Obstet Gynecol 205(2):1–8
Fellermann K, Stange EF (2001) Defensins—innate immunity at the epithelial frontier. Eur J Gastroenterol Hepatol 13(7):771–776
Frew L, Stock SJ (2011) Antimicrobial peptides and pregnancy. Reproduction 141(6):725–735
Frew L, Makieva S, McKinlay AT, McHugh BJ, Doust A, Norman JE, Davidson DJ, Stock SJ (2014) Human cathelicidin production by the cervix. PLoS ONE 9(8):e103434
Harder J, Bartels J, Christophers E, Schroder JM (2001) Isolation and characterization of human beta-defensin-3, a novel human inducible peptide antibiotic. J Biol Chem 276(8):5707–5713
Hein M, Valore EV, Helmig RB, Uldbjerg N, Ganz T (2002) Antimicrobial factors in the cervical mucus plug. Am J Obstet Gynecol 187(1):137–144
Iams JD, Romero R, Culhane JF, Goldenberg RL (2008) Primary, secondary, and tertiary interventions to reduce the morbidity and mortality of preterm birth. Lancet 371(9607):164–175
Jansen PA, Rodijk-Olthuis D, Hollox EJ, Kamsteeg M, Tjabringa GS, de Jongh GJ, van Vlijmen-Willems IM, Bergboer JG, van Rossum MM, de Jong EM, den Heijer M, Evers AW, Bergers M, Armour JA, Zeeuwen PL, Schalkwijk J (2009) Beta-defensin-2 protein is a serum biomarker for disease activity in psoriasis and reaches biologically relevant concentrations in lesional skin. PLoS ONE 4(3):e4725
Jones HE, Harris KA, Azizia M, Bank L, Carpenter B, Hartley JC, Klein N, Peebles D (2009) Differing prevalence and diversity of bacterial species in fetal membranes from very preterm and term labor. PLoS ONE 4(12):e8205
King AE, Fleming DC, Critchley HO, Kelly RW (2003) Differential expression of the natural antimicrobials, beta-defensins 3 and 4, in human en-dometrium. J Reprod Immunol 59(1):1–16
Lucovnik M, Kornhauser-Cerar L, Premru-Srsen T, Gmeiner-Stopar T, Derganc M (2011) Neutrophil defensins but not interleukin-6 in vaginal fluid after preterm premature rupture of membranes predict fetal/neonatal inflammation and infant neurological impairment. Acta Obstet Gynecol Scand 90(8):908–916
Maggio L, Rouse DJ (2014) Progesterone. Clin Obstet Gynecol 57(3):547–556
Marlow N, Wolke D, Bracewell MA, Samara M (2005) Neurologic and developmental disability at six years of age after extremely preterm birth. N Engl J Med 352(1):9–19
Moore T, Hennessy EM, Myles J, Johnson SJ, Draper ES, Costeloe KL, Marlow N (2012) Neurological and developmental outcome in extremely preterm children born in England in 1995 and 2006: the EPICure studies. BMJ 345:e7961
Nold C, Maubert M, Anton L, Yellon S, Elovitz MA (2013) Prevention of preterm birth by progestational agents: what are the molecular mechanisms? Am J Obstet Gynecol 208(3):1–7
Pazgier M, Hoover DM, Yang D, Lu W, Lubkowski J (2006) Human beta-defensins. Cell Mol Life Sci 63(11):1294–1313
Pazgier, M, Prahl, A, Hoover, DM, Lubkowski, J (2007) Studies of the biological properties of human beta-defensin 1. J Biol Chem 19, 282(3):1819–29
Polettini J, Takitane J, Peracoli JC, Silva MG (2011) Expression of defensins 1, 3 and 4 in chorioamniotic membranes of preterm pregnancies complicated by chorioamnionitis. Eur J Obstet Gynecol Reprod Biol 157(2):150–155
Prado-Montes de Oca E (2010) Human beta-defensin 1: a restless warrior against allergies, infections and cancer. Int J Biochem Cell Biol 42(6):800–804
Röhrl J, Yang D, Oppenheim JJ, Hehlgans T (2010) Human beta-defensin 2 and 3 and their mouse orthologs induce chemotaxis through interaction with CCR2. J Immunol 15, 184(12):6688–94
Semple F, Webb S, Li HN, Patel HB, Perretti M, Jackson IJ, Gray M, Davidson DJ, Dorin JR (2010) Human beta-defensin 3 has immunosuppressive activity in vitro and in vivo. Eur J Immunol 40(4):1073–1078
Semple F, MacPherson H, Webb S, Cox SL, Mallin LJ, Tyrrell C, Grimes GR, Semple CA, Nix MA, Millhauser GL, Dorin JR (2011) Human—defensin 3 affects the activity of pro-inflammatory pathways associated with MyD88 and TRIF. Eur J Immunol 41(11):3291–3300
Stock SJ, Duthie L, Tremaine T, Calder AA, Kelly RW, Riley SC (2009) Elafin (SKALP/Trappin-2/proteinase inhibitor-3) is produced by the cervix in pregnancy and cervicovaginal levels are diminished in bacterial vaginosis. Reprod Sci 16(12):1125–1134
Tita AT, Andrews WW (2010) Diagnosis and management of clinical chorioamnionitis. Clin Perinatol 37(2):339–354
Wiesner J, Vilcinskas A (2010) Antimicrobial peptides: the ancient arm of the human immune system. Virulence 1(5):440–464
Wira CR, Rodriguez-Garcia M, Patel MV (2015) The role of sex hormones in immune protection of the female reproductive tract. Nat Rev Immunol 15(4):217–230
Xu J, Holzman CB, Arvidson CG, Chung H, Goepfert AR (2008) Midpreg- nancy vaginal fluid defensins, bacterial vaginosis, and risk of preterm delivery. Obstet Gynecol 112(3):524–531
Zasloff M (2002) Antimicrobial peptides of multicellular organisms. Nature 415(6870):389–395
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
James, C.P., Bajaj-Elliott, M. (2016). Antimicrobial Peptides and Preterm Birth. In: Epand, R. (eds) Host Defense Peptides and Their Potential as Therapeutic Agents. Springer, Cham. https://doi.org/10.1007/978-3-319-32949-9_11
Download citation
DOI: https://doi.org/10.1007/978-3-319-32949-9_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-32947-5
Online ISBN: 978-3-319-32949-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)